Home >> Report Store >> Healthcare >> Gastrointestinal Therapeutics Market – Global Forecast to 2025 >

Gastrointestinal Disease Treatment Market, By Types (Branded, Proton Pump Inhibitors, Enzyme Replacement Therapies, Amino-salicylates, Antacids, Anti-emetics, Anti-diarrheal, Biologics, and Others and Generics), By Route (Oral, IV, Others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025

107 Pages | Published Date : 12 / 12 / 17  | Report Code: AV144 | Report Format: PDF

REPORT HIGHLIGHT

The gastrointestinal disease treatment market is estimated to represent a global market of USD 34.8 billion by 2017 with growth rate of 5.8%.

Market Dynamics

Gastrointestinal disorders are functional disorders that affect the sections of GIT track and its accessory organs such as the pancreas, salivary glands, and liver. This disorder includes chronic, acute, recurrent as well as functional disorders which cover wide range of GIT track diseases. Some of the most common GIT disorders include Crohn’s disease, GIT cancers, inflammatory bowel disease, irritable bowel syndrome, diarrhea, dyspepsia, and others. The continuous increase in the prevalence of these diseases is expected to support the market growth to great extent.

As per the World Health Organizations, colon cancer caused more than 694 000 deaths in 2014. A report published by the American Cancer Society also stated that around 100,000 colon cancer cases were diagnosed in the U.S. alone, which is expected to increase by 62% till 2030. Such high prevalence rate will upsurge the demand for GIT therapeutics, leading to driving the market growth. Additionally, the emergence of novel therapeutics such as biosimilar is considered to be the most important driver for this market. Biosimilar contains identical active pharmaceutical ingredients which offer effective treatment for the GIT disorders such as inflammatory disorders and others. Rise in the usage of biologics for the treatment of GIT disorders is also anticipated to encourage the market growth.

Furthermore, according to the various research studies, the social and economic burden of GIT disorders are enormous. For instance, in December 2015, the article published by an online publication “Gastroenterology” stated that gastrointestinal disease is the source of substantial burden in terms of mortality, morbidity, and cost to the U.S. population. Therefore, various organizations such as the World Journal of Gastrointestinal Pharmacology and Therapeutics (WJGPT) are actively devoted to encouraging scientists to develop novel therapeutics to cure this disease, providing the healthy platform for the market growth.

However, patient expiry for some of the blockbuster therapeutics hampers the market growth to some extent. Humira that accounted for more than 55% share of biologics used for the treatment of gastrointestinal diseases, expired in 2016. This has caused a steep decline in the revenue generated by gastrointestinal therapeutics.

Types Takeaway

The market is majorly categorized as Branded and Generics. The branded segment accounted for the largest share of the total market, captured more than 72.56% share in 2017. Branded segment is further categorized as Proton Pump Inhibitors, Enzyme Replacement Therapies, Amino-salicylates, Antacids, Anti-emetics, Anti-diarrheal, Biologics, and Others. Of these, proton pump inhibitors recorded the highest revenue i.e. USD 4.8 billion in 2017.

However, the segment is projected to grow with the negative growth rate over the forecast period owing to the loss of patent and exclusivity of major drugs, such as Nexium and Prilosec. Among the different drug class, biologics are anticipated to grow with the highest growth rate, i.e. 11.6% over the forecast period. In 2025, this segment is projected to lead the market with more than USD 17.4 billion revenue generation.

Route of Administration Takeaway

The route of administration segment is divided as Oral, IV, Others. Both oral and intravenous route of administration captured the significant share of the total market owing to the availability of safe and effective therapeutics that can be administered through oral and intravenous route.In terms of application, the market is categorized as Crohn’s disease, Ulcerative colitis, GERD, and Others. Purchase of GIT therapeutics from retail pharmacies accounted for the largest share among the different distribution channels. However, the online channel is believed to grow at highest growth during the future period.

North America Gastrointestinal Disease Treatment Market

Regional Takeaway

Geographically, North America dominated the global market. In 2017, the region recorded USD 14.48 billion and is projected to dominate the market in future. Favorable government initiatives to increase the uptake of gastrointestinal therapeutics drive the market growth in this region. For instance, the Integrated Global Action Plan for Diarrhoea by UNICEF and WHO aims at minimizing preventable childhood deaths due to diarrhea by providing interventions and services to raise awareness and provide access to treatment and preventive measures. However, Asia Pacific region is expected to grow with the highest CAGR over the forecast period.

Key Vendor Takeaway

The report also discusses the leading players in global gastrointestinal therapeutics market. The report enlists companies such as Abbott, Allergan, GlaxoSmithKline plc, Takeda Pharmaceutical and Pfizer, Inc., among others. Strategic collaboration and new product proliferation have made this market very dynamic. The collaboration of multinational companies with small-scale participants creates rivalry among key players.

For example, in September 2017, Takeda Pharmaceuticals collaborated with Structural Genomics Consortium (SGC) to develop new intervention methods for the treatment of inflammatory bowel disease. This implies that strategic engagement to expand product offering is considered to be one of the most factors.

The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.

The years considered for the study are:

  • Historical Year – 2014 & 2015
  • Base Year – 2015
  • Estimated Year – 2016
  • Projected Year – 2025

TARGET AUDIENCE

  • Traders, Distributors, And Suppliers
  • Manufacturers
  • Hospitals
  • Government and Regional Agencies and Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY TYPES

  • Branded
    • Proton Pump Inhibitors
    • Enzyme Replacement Therapies
    • Amino-salicylates
    • Antacids
    • Anti-emetics
    • Anti-diarrheal
    • Biologics
    • Others
  • Generics

MARKET, BY ROUE OF ADMINISTRATION

  • Oral
  • IV
  • Others

MARKET, BY REGION

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

MARKET, BY COUNTRY

  • Further Breakdown of The North America Market
    • U.S.
    • Canada
  • Further Breakdown of The Europe Market
    • Germany
    • France
    • Rest of Europe
  • Further Breakdown of The APAC Market
    • India
    • China
    • Rest of APAC
  • Further Breakdown of The Rest of the World Market
    • Middle East and Africa
    • Latin America
TABLE OF CONTENT

1. GASTROINTESTINAL DISEASE TREATMENT MARKET OVERVIEW
1.1. Study Scope
1.2. Base Year
1.3. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. GASTROINTESTINAL DISEASE TREATMENT KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. GASTROINTESTINAL DISEASE TREATMENT INDUSTRY STUDY
4.1. Company Activity Analysis
4.2. Regulatory Framework Analysis
4.3. Market Attractiveness Analysis
4.4. Value Chain Analysis
5. GASTROINTESTINAL DISEASE TREATMENT MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
6. GASTROINTESTINAL DISEASE TREATMENT MARKET – BY DRUG CATEGORY:
6.1. Overview
6.2. Branded
6.2.1.1. Overview
6.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.2. Proton Pump Inhibitors
6.2.2.1. Overview
6.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.3. Enzyme Replacement Therapies
6.2.3.1. Overview
6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.4. Amino-salicylates
6.2.4.1. Overview
6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.5. Antacids
6.2.5.1. Overview
6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.6. Anti-emetics
6.2.6.1. Overview
6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.7. Anti-diarrheal
6.2.7.1. Overview
6.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.8. Biologics
6.2.8.1. Overview
6.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.2.9. Others
6.2.9.1. Overview
6.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3. Generics
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. GASTROINTESTINAL DISEASE TREATMENT MARKET – BY ROUE OF ADMINISTRATION:
7.1. Overview
7.2. Oral
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3. IV
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4. Others
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. GASTROINTESTINAL DISEASE TREATMENT MARKET– BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.2.3. U.S.
8.2.3.1. Overview
8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.2.4. Canada
8.2.4.1. Overview
8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.3. France
8.3.3.1. Overview
8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.4. Germany
8.3.4.1. Overview
8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.5. Rest of Europe
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.3. China
8.4.3.1. Overview
8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.4. India
8.4.4.1. Overview
8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.5. Rest of APAC
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5. Rest of the World
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.3. Latin America
8.5.3.1. Overview
8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.4. Middle East and Africa
8.5.4.1. Overview
8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. Abbott
9.1.1. Company Overview
9.1.2. SWOT Analysis
9.1.3. Key Developments
9.2. Allergan
9.2.1. Company Overview
9.2.2. SWOT Analysis
9.2.3. Key Developments
9.3. GlaxoSmithKline plc
9.3.1. Company Overview
9.3.2. SWOT Analysis
9.3.3. Key Developments
9.4. Phillips Healthcare
9.4.1. Company Overview
9.4.2. SWOT Analysis
9.4.3. Key Developments
9.5. Takeda Pharmaceutical
9.5.1. Company Overview
9.5.2. SWOT Analysis
9.5.3. Key Developments
9.6. Pfizer, Inc.
9.6.1. Company Overview
9.6.2. SWOT Analysis
9.6.3. Key Developments
*Client can request additional company profiling as per specific requirements
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. Abbreviations
11.3. Disclaimer
11.4. Contact Us

List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Gastrointestinal Disease Treatment Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
Table 10 Gastrointestinal Disease Treatment Market, by Drug Cateory, 2014 – 2025 (USD Million)
Table 11 Gastrointestinal Disease Treatment Market, by Route of Administration, 2014 – 2025 (USD Million)
Table 12 Gastrointestinal Disease Treatment Market, by Geography, 2014 – 2025 (USD Million)
Table 13 North America Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 14 U.S. Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 15 Canada Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 16 Europe Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 17 France Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 18 Germany Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 19 Asia Pacific Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 20 China Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 21 India Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 22 Latin America Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)
Table 23 MEA Gastrointestinal Disease Treatment Market, 2014 – 2025 (USD Million)

List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Value Chain Analysis Analysis
Figure 6 Gastrointestinal Disease Treatment Market, by Drug Category, 2014 – 2025 (USD Million)
Figure 7 Gastrointestinal Disease Treatment Market, by Route of Administration, 2014 – 2025 (USD Million)
Figure 8 Gastrointestinal Disease Treatment Market, by Geography, 2014 – 2025 (USD Million)

SCOPE AND OBJECTIVES :
The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the market. The scope of this report covers the market by its major segments.

KEY BENEFITS OF THE REPORT :
• Understanding of the strategies that are being adopted by the key players in this market to stay competitive
• Extensive analysis of the key players dominating the competitive landscape of this market
• In-depth analysis of the key factors are propelling the growth of the global market
• Detailed analysis of the geographic region that will witness the strongest growth
• Granular analysis of the current market scenario and the expected market grow

RESEARCH METHDOLOGY

AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:

  • Official Company’s Website, Financial and Annual Reporting
  • Government Statistical Data
  • Online Publishing Articles
  • Industry Player’s Investor Presentations
  • Economic News Articles
  • National and International Trade Associations
  • The Financial, Business and Mainstream Press
  • Industry Study Groups and Other Semi-Official Sources
  • Many Other Informative Channels Related to the Market Topics
  • Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide

In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level.

MARKET FORECAST

Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario.

 MARKET ANALYSIS

Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.

Why AnalystView?

Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.

Y

Tailor Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.

T

Data Accuracy And Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This